Here’s how remote visual inspection (RVI) can help pharma companies prevent contamination and maintain product-line purity requirements.
Drug manufacturers use a combination of indirect and direct quality control (QC) techniques to prevent contamination throughout the production line. Image courtesy of Olympus
Hafees Fraisada, Olympus
Bacterial or foreign-particle contamination in production-line equipment can cause serious health issues for consumers and shake public confidence in the industry.
Strict purity and contamination control of pharmaceutical manufacturing facilities is required under various international standards, such as ASME (American Society of Mechanical Engineers), AWS (American Welding Society) and local regulatory authorities such as the U.S. Food and Drug Administration.
Get the full story from our sister site, Pharmaceutical Processing World.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees.
